Evidence map›Paper›PMID 21602662›Full record

ArticleAnesthesiology2011

Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology.

Kirsty Bannister, Shafaq Sikandar, Claudia S Bauer, Annette C Dolphin, Frank Porreca, Anthony H Dickenson

Open access · bronzeAbstract read
In one paragraph

Article in Anesthesiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Calcium Channel αPain and therapy · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Pregabalin as a Pain Therapeutic: Beyond Calcium Channels.Frontiers in cellular neuroscience · 2020
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Cancer pain physiology.British journal of pain · 2014
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Kirsty BannisterDepartment of Neuroscience, Pharmacology and Physiology, University College London, London, UK. kirsty.bannister@ucl.ac.uk
Shafaq Sikandar
Claudia S Bauer
Annette C Dolphin
Frank Porreca
Anthony H Dickenson
University College London · GBUniversity of Arizona · US

Funding

SPINAL DYNORPHIN AND OPIOID TOLERANCER01DA012656 · NIDA · UNIVERSITY OF ARIZONA · PI PORRECA, FRANK · 1999 to 2011
$2.3M
British Heart Foundation 19444Medical Research Council G0700368NIDA NIH HHS R01 DA012656
6 · The paper itself

Abstract

backgroundOpioid-induced hyperalgesia is recognized in the laboratory and the clinic, generating central hyperexcitability in the absence of peripheral pathology. We investigated pregabalin, indicated for neuropathic pain, and ondansetron, a drug that disrupts descending serotonergic processing in the central nervous system, on spinal neuronal hyperexcitability and visceral hypersensitivity in a rat model of opioid-induced hyperalgesia.

methodsMale Sprague-Dawley rats (180-200 g) were implanted with osmotic mini-pumps filled with morphine (90 μg · μl⁻¹ · h⁻¹) or saline (0.9% w/v). On days 7-10 in isoflurane anesthetized animals, we evaluated the effects of (1) systemic pregabalin on spinal neuronal and visceromotor responses, and (2) spinal ondansetron on dorsal horn neuronal response. Messenger ribonucleic acid concentrations of α2δ-1, 5HT3A, and μ-opioid receptor in the dorsal root ganglia of all animals were analyzed.

resultsIn morphine-treated animals, evoked spinal neuronal responses were enhanced to a subset of thermal and mechanical stimuli. This activity was attenuated by pregabalin (by at least 71%) and ondansetron (37%); the visceromotor response to a subset of colorectal distension pressures was attenuated by pregabalin (52.8%; n = 8 for all measures, P < 0.05). Messenger ribonucleic acid concentrations were unchanged.

conclusionsThe inhibitory action of pregabalin in opioid-induced hyperalgesia animals is neither neuropathy-dependent nor reliant on up-regulation of the α₂δ-1 subunit of voltage-gated calcium channels-mechanisms proposed as being essential for pregabalin's efficacy in neuropathy. In opioid-induced hyperalgesia, which extends to colonic distension, a serotonergic facilitatory system may be up-regulated, creating an environment that is permissive for pregabalin-mediated analgesia without peripheral pathology.

Indexed as

AnalgesicsAnalgesics, OpioidAnimalsDilatationElectrophysiologygamma-Aminobutyric AcidHyperalgesiaMaleMorphineNeuronsOndansetronPainPain MeasurementPregabalinRatsRats, Sprague-DawleyAnalgesicsAnalgesics, Opioidgamma-Aminobutyric AcidMorphineOndansetronPregabalinReceptors, Opioid, muReceptors, Serotonin, 5-HT3RNA, MessengerSerotonin Antagonists

Identifiers

PMID21602662
PMCPMC3427727
OpenAlexW2088282278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.